Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

CPH

Cipher Pharmaceuticals (CPH)

Cipher Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSX:CPH
DatumZeitQuelleÜberschriftSymbolFirma
09/05/202423h00PR Newswire (Canada)Cipher Pharmaceuticals Reports First Quarter 2024 ResultsTSX:CPHCipher Pharmaceuticals Inc
03/05/202413h05PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
14/03/202422h00PR Newswire (Canada)Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 ResultsTSX:CPHCipher Pharmaceuticals Inc
08/03/202413h00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
29/01/202418h56AllPennyStocks.comWill Uplisting Be the Catalyst to Send Shares of this Pharma Company Higher?TSX:CPHCipher Pharmaceuticals Inc
29/01/202418h56AllPennyStocks.comWill Uplisting Be the Catalyst to Send Sharesof this Pharma Company Higher?TSX:CPHCipher Pharmaceuticals Inc
29/01/202413h15PR Newswire (Canada)Cipher Pharmaceuticals Announces the Commencement of OTCQX TradingTSX:CPHCipher Pharmaceuticals Inc
24/11/202323h00PR Newswire (Canada)Cipher Pharmaceuticals Announces Change of AuditorTSX:CPHCipher Pharmaceuticals Inc
15/11/202323h00PR Newswire (Canada)Cipher Pharmaceuticals Announces Normal Course Issuer BidTSX:CPHCipher Pharmaceuticals Inc
09/11/202323h00PR Newswire (Canada)Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023TSX:CPHCipher Pharmaceuticals Inc
27/10/202313h00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
12/10/202315h57PR Newswire (Canada)Cipher Pharmaceuticals Announces Final Results of Substantial Issuer BidTSX:CPHCipher Pharmaceuticals Inc
03/10/202313h00PR Newswire (Canada)Cipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer BidTSX:CPHCipher Pharmaceuticals Inc
05/09/202313h00PR Newswire (Canada)Cipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian DollarsTSX:CPHCipher Pharmaceuticals Inc
10/08/202323h00PR Newswire (Canada)Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in MexicoTSX:CPHCipher Pharmaceuticals Inc
28/07/202313h00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
05/07/202313h00PR Newswire (Canada)Cipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European UnionTSX:CPHCipher Pharmaceuticals Inc
21/06/202318h53PR Newswire (Canada)Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of ShareholdersTSX:CPHCipher Pharmaceuticals Inc
11/05/202323h00PR Newswire (Canada)Cipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial FlexibilityTSX:CPHCipher Pharmaceuticals Inc
04/05/202323h00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
16/03/202322h00PR Newswire (Canada)Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
10/03/202323h30PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
01/03/202313h00PR Newswire (Canada)Cipher Pharmaceuticals Announces Closing of New US$35 Million Credit FacilityTSX:CPHCipher Pharmaceuticals Inc
11/11/202200h30PR Newswire (Canada)Cipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per ShareTSX:CPHCipher Pharmaceuticals Inc
26/10/202213h00PR Newswire (Canada)CIPHER PHARMACEUTICALS SCHEDULES Q3 2022 EARNINGS RELEASE AND CONFERENCE CALLTSX:CPHCipher Pharmaceuticals Inc
19/09/202223h00PR Newswire (Canada)Cipher Pharmaceuticals Announces Normal Course Issuer BidTSX:CPHCipher Pharmaceuticals Inc
11/08/202223h45PR Newswire (Canada)Cipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFOTSX:CPHCipher Pharmaceuticals Inc
11/08/202223h01PR Newswire (Canada)Cipher Pharmaceuticals Reports Second Quarter 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
05/08/202213h00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
22/06/202223h01PR Newswire (Canada)Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John MullTSX:CPHCipher Pharmaceuticals Inc
 Showing the most relevant articles for your search:TSX:CPH